Research Article
[Retracted] Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
Table 4
Comparison of the recurrence of the three groups of high-risk bladder cancer patients.
| | Number of recurrences in 1 year | 1-year recurrence rate | Number of recurrences in 2 years | 2-year recurrence rate |
| Group A (n = 67) | 7 | 10.45% | 17 | 25.37% | Group B (n = 81) | 3 | 3.7% | 8 | 9.87% | Group C (n = 74) | 9 | 13.16% | 18 | 24.32% | All groups | | | | | X2 | | 3.97 | | 7.38 | value | | 0.137 | | 0.025 | Group A vs. B | | | | | X2 | | 2.65 | | 6.27 | value | | 0.104 | | 0.012 (<0.017) | Group B vs. C | | | | | X2 | | 3.87 | | 5.78 | value | | 0.049 (>0.017) | | 0.016 (<0.017) | Group A vs. C | | | | | X2 | | 0.10 | | 0.02 | value | | 0.749 | | 0.886 |
|
|